articleThe LancetJul 1, 2007Closed access

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

MKMiriam KoopmanNANinja AntoniniJDJoep DoumaJWJ. WalsAHAafke H. Honkoop

Radboud University Medical Center · Radboud University Nijmegen · +16 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

631
total citations
FWCI
26.22
Percentile
100%
References
28
Citations per year

Authors

19

Topics & keywords

Topics
Keywords
  • Capecitabine
  • Irinotecan
  • Oxaliplatin
  • Medicine
  • Colorectal cancer
  • Internal medicine
  • Oncology
  • Chemotherapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding